1416469-35-6

Basic information

• Product Name: tert-butyl [(2R)-4-{4-[(4aS,8aR)-4-(3,4-dimethoxyphenyl)-1-oxo-4a,5,6,7,8,8a-hexahydrophthalazin-2(1H)-yl]piperidin-1-yl}-4-oxo-1-phenylbutan-2-yl]carbamate
• Synonyms: tert-butyl [(2R)-4-{4-[(4aS,8aR)-4-(3,4-dimethoxyphenyl)-1-oxo-4a,5,6,7,8,8a-hexahydrophthalazin-2(1H)-yl]piperidin-1-yl}-4-oxo-1-phenylbutan-2-yl]carbamate
• CAS NO: 1416469-35-6
• Molecular Weight: 632.8
• Mol File: 1416469-35-6.mol

Chemical Properties

• CAS DataBase Reference: tert-butyl [(2R)-4-{4-[(4aS,8aR)-4-(3,4-dimethoxyphenyl)-1-oxo-4a,5,6,7,8,8a-hexahydrophthalazin-2(1H)-yl]piperidin-1-yl}-4-oxo-1-phenylbutan-2-yl]carbamate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl [(2R)-4-{4-[(4aS,8aR)-4-(3,4-dimethoxyphenyl)-1-oxo-4a,5,6,7,8,8a-hexahydrophthalazin-2(1H)-yl]piperidin-1-yl}-4-oxo-1-phenylbutan-2-yl]carbamate(1416469-35-6)
• EPA Substance Registry System: tert-butyl [(2R)-4-{4-[(4aS,8aR)-4-(3,4-dimethoxyphenyl)-1-oxo-4a,5,6,7,8,8a-hexahydrophthalazin-2(1H)-yl]piperidin-1-yl}-4-oxo-1-phenylbutan-2-yl]carbamate(1416469-35-6)

Safety Data

• Hazardous Substances Data: 1416469-35-6(Hazardous Substances Data)

Upstream product

• 666748-56-7 (4aS,8aR)-4-(3,4-dimethoxyphenyl)-2-(piperidin-4-yl)-4a,5,6,7,8,8a-hexahydrophthalazin-1(2H)-one hydrochloride 
• 101555-61-7 (R)-3-t-butoxycarbonylamino-4-phenylbutyric acid 

Downstream Products

• 1416467-81-6 4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-N-[(2R)-4-{4-[(4aS,8aR)-4-(3,4-dimethoxyphenyl)-1-oxo-4a,5,6,7,8,8a-hexahydrophthalazin-2(1H)-yl]piperidin-1-yl}-4-oxo-1-phenylbutan-2-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide 
• 1416469-36-7 (4aS,8aR)-2-{1-[(3R)-3-amino-4-phenylbutanoyl]piperidin-4-yl}-4-(3,4-dimethoxyphenyl)-4a,5,6,7,8,8a-hexahydrophthalazin-1(2H)-one 

Relevant articles and documents

NOVEL PHTHALAZINONE-PYRROLOPYRIMIDINECARBOXAMIDE DERIVATIVES

The compounds of formula (1) in which R1, R7, R8, R9, R10, R17, R18, R19, R20 and m have the meanings as given in the description, are novel effective inhibitors of type 4 and type 5 phosphodiesterase.

NOVEL PHTHALAZINONE-PYRROLOPYRIMIDINECARBOXAMIDE DERIVATIVES

The compounds of formula (1), in which R1, R7, R8, R9, R10, R17, R18, R19, R20 and m have the meanings as given in the description, are novel effective inhibitors of type 4 and 5 phosphodiesterase.